Alerts will be sent to your verified email
Verify Email
BIOGEN
|
Biogen Pharmachem
|
Cerebra Integ. Tech
|
Le Lavoir
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.21 % | -1.34 % | 7.23 % |
|
5yr average Equity Multiplier
|
1.01 | 1.52 | 1.25 |
|
5yr Average Asset Turnover Ratio
|
0.02 | 0.3 | 0.21 |
|
5yr Avg Net Profit Margin
|
-19.83 % | -13.9 % | 23.48 % |
|
Price to Book
|
1.17 | 0.36 | 9.59 |
|
P/E
|
0.0 | 0.0 | 43.95 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 765.04 Days | 40.73 Days |
|
Inventory Days
|
0.0 | 113.07 Days | 10.35 Days |
|
Days Receivable
|
0.0 | 916.46 Days | 136.08 Days |
|
Days Payable
|
1109.22 Days | 375.27 Days | 222.35 Days |
|
5yr Average Interest Coverage Ratio
|
902.8 | 1.54 | 733.28 |
|
5yr Avg ROCE
|
0.21 % | 3.66 % | 9.3 % |
|
5yr Avg Operating Profit Margin
|
-19.88 % | -2.53 % | 21.57 % |
|
5 yr average Debt to Equity
|
0.0 | 0.11 | 0.05 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
0.21 % | -0.8 % | 5.7 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 0.84 % | 3.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -6.26 % | -1.15 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Biogen Pharmachem
|
Cerebra Integ. Tech
|
Le Lavoir
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|